ArticleCancer cell2025

Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancer.

Jennifer R Grandis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.